DXCM

Dexcom Inc

78.32

Oct 22 • 3:59 PM ET -1.94 (-2.42%)

79.44

Aftermarket • 7:53 PM ET +1.12 (1.43%)

Healthcare Medical Devices USA Large NASD

Oct 21, 12:02 PMAbbott earnings readthrough pressures Dexcom 6.6% as competitor CGM growth slows ahead of Dexcom earnings

Peers: ABT PODD SENS MMED TNDM MDT BBNX IRTC BSX RMD

| Held by: VTI VOO VO QQQ VUG IVV SPY VOT XLV RSP

Scroll to Statements

Index	NDX, S&P 500
Market Cap	29.55B
Enterprise Value	29.01B
Income	999.70M
Sales	4.97B
Book/sh	6.95
Cash/sh	5.16
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	11100
IPO	Apr 14, 2005

P/E	30.91
Forward P/E	25.03
PEG	1.17
P/S	5.95
P/B	11.28
P/C	15.18
P/FCF	21.04
EV/EBITDA	20.67
EV/Sales	5.84
Quick Ratio	1.43
Current Ratio	1.73
Debt/Eq	0.53
LT Debt/Eq	0.53
Option/Short	Yes / Yes

EPS (ttm)	2.53
EPS next Y	3.13
EPS next Q	0.67
EPS this Y	27.85%
EPS next Y	17.08%
EPS next 5Y	21.35%
EPS past 3/5Y	37.83% 10.55%
Sales past 3/5Y	17.01% 19.33%
EPS Y/Y TTM	77.43%
Sales Y/Y TTM	15.54%
EPS Q/Q	43.63%
Sales Q/Q	13.08%
Earnings	Oct 29 AMC
EPS/Sales Surpr.	14.59% 1.40%

Insider Own	1.65%
Insider Trans	-2.41%
Inst Own	104.94%
Inst Trans	0.79%
ROA	14.51%
ROE	38.49%
ROIC	25.00%
Gross Margin	63.57%
Oper. Margin	22.92%
Profit Margin	20.12%
SMA20	-7.83%
SMA50	-10.08%
SMA200	5.46%
Trades

Shs Outstand	377.40M
Shs Float	371.12M
Short Float	3.78%
Short Ratio	3.21
Short Interest	14.02M
52W High	92.59 -15.41%
52W Low	54.11 44.74%
Volatility	3.89% 2.80%
ATR (14)	2.68
RSI (14)	32.69
Beta	1.45
Rel Volume	2.47
Avg Volume	4.37M
Volume	10,794,304

Perf Week	-10.71%
Perf Month	-10.73%
Perf Quarter	9.48%
Perf Half Y	24.91%
Perf YTD	18.01%
Perf Year	10.78%
Perf 3Y	-8.90%
Perf 5Y	-44.71%
Perf 10Y	288.30%
Recom	1.44
Target Price	97.36
Prev Close	80.26
Price	78.32
Change %	-2.42%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-07-26	Initiated	Barclays	Overweight	$115
Jun-23-26	Initiated	Deutsche Bank	Buy	$86
May-12-26	Initiated	The Benchmark Company	Buy	$77
Mar-24-26	Upgrade	Evercore ISI	In-line → Outperform	$90
Jan-12-26	Downgrade	Barclays	Equal Weight → Underweight	$71
Dec-02-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$75
Nov-25-25	Initiated	Evercore ISI	In-line	$68
Oct-21-25	Resumed	Stifel	Buy	$85
Sep-08-25	Downgrade	Oppenheimer	Outperform → Perform
Aug-21-25	Initiated	Argus	Buy	$100
Jun-16-25	Initiated	Truist	Buy	$102
May-30-25	Initiated	Goldman	Buy	$104
Apr-10-25	Initiated	Mizuho	Outperform	$85
Feb-03-25	Upgrade	Redburn Atlantic	Neutral → Buy	$85 → $115
Jan-16-25	Upgrade	Robert W. Baird	Neutral → Outperform	$86 → $104
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131

Show Previous Ratings

Oct-21-26 06:59PM	DexCom's Whisper Bar Sits Above Consensus As Ireland Costs Test Its Margin Story (Earnings Whispers) -6.39%
04:59PM	7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
04:30PM	DexCom Inc. stock underperforms Wednesday when compared to competitors (MarketWatch)
Oct-15-26 11:53AM	NEJM study supports CGM use for people with diabetes who dont take insulin (MedTech Dive) +5.08%
Oct-14-26 05:10PM	Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin (Business Wire)
02:07PM	Loading…
Oct-12-26 02:07PM	Ascensia leads $36M funding round for glucose sensor startup (MedTech Dive)
Oct-08-26 03:40AM	Citi reiterates these 2 medtech stocks as its top picks in the sector (Investing.com)
Oct-07-26 10:00AM	Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls (The Fly)
08:30AM	Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time (Business Wire)
Oct-06-26 09:00AM	Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading (Business Wire)
Oct-02-26 03:27PM	Why Medtronic's $4 Billion MiniMed Exchange Offer Is Losing Its Allure (Barrons.com)
Sep-28-26 04:25PM	Why DexCom Could Be the Big Winner Out of Oura's IPO (Barrons.com)
02:00AM	Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care (Business Wire)
Sep-15-26 11:33PM	Dexcom gives CFO Jereme Sylvain expanded role (MedTech Dive)
Sep-14-26 04:30PM	Dexcom Promotes Jereme Sylvain to Chief Operating Officer (Business Wire)
04:15PM	Loading…
Sep-10-26 04:15PM	Dexcom Appoints Glenn Boehnlein to Board of Directors (Business Wire)
Sep-07-26 03:27PM	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Sep-03-26 01:51AM	Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services (Barrons.com)
Sep-01-26 08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
Aug-27-26 05:47PM	Analysts' Top S&P 500 Stocks to Buy Now (Kiplinger)
06:09AM	Dexcom, Abbott await Medicare coverage expansion for CGMs (MedTech Dive)
Aug-24-26 07:05PM	Oura is reportedly eyeing a September IPO that could value it at more than $16B (TechCrunch)
Aug-18-26 04:30PM	Insulet Corp. stock outperforms competitors on strong trading day (MarketWatch)
Jul-31-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +11.95%
11:20AM	Dexcom tweaks full-year outlook after reporting 13% growth in Q2 (Medical Device Network)
01:04AM	DexCom Inc (DXCM) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Jul-30-26 04:09PM	DexCom: Q2 Earnings Snapshot (Associated Press)
Jul-29-26 04:52PM	Align Technology to add directors, launch review after deal with Elliott (Reuters)
09:12AM	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Jul-28-26 09:34AM	Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls (The Fly)
05:15PM	Loading…
Jul-22-26 05:15PM	Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program (Business Wire)
04:30PM	DexCom Inc. stock underperforms Wednesday when compared to competitors (MarketWatch)
Jul-16-26 04:30PM	DexCom Inc. stock underperforms Thursday when compared to competitors despite daily gains (MarketWatch) +7.22%
Jul-10-26 08:08AM	DXCM Grew. The Stock Did Not. Someone Is Wrong (Trefis)
Jul-09-26 08:30AM	Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time (Business Wire)
Jul-08-26 05:38PM	Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM (Exec Edge)
Jul-07-26 07:10AM	Insulet launches Omnipod 5 in Spain (MedTech Dive)
Jul-03-26 12:27PM	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Jun-23-26 09:00AM	Dexcom Further Advances Vision of Glucose Biosensing for All (Business Wire)
Jun-18-26 02:14PM	Living Longer Is Big Business. These Stocks Will Benefit. (Barrons.com)
12:03PM	FiberSense plans CGMs commercial readiness following CE mark (Medical Device Network)
Jun-09-26 04:30PM	Insulet Corp. stock outperforms competitors on strong trading day (MarketWatch)
Jun-08-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.16%
Jun-06-26 02:45PM	Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin (Business Wire)
Jun-05-26 06:25AM	Dexcom buys Nutrisense; Insulet rolls out patch pump update (MedTech Dive)
Jun-04-26 09:00AM	Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026 (Business Wire)
May-27-26 09:44AM	Signos raises $20M, expands Dexcom partnership for weight loss (Quartz)
09:44AM	Glucose-tracking startup Signos is raising $20M and expanding its Dexcom partnership (Quartz)
May-26-26 09:30AM	Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users (Business Wire)
May-22-26 04:36PM	QuantumCore Announces Changes to Board of Directors (TMX Newsfile)
11:12AM	Harnessing medtech market alliances, URA sets IPO plans in motion (Medical Device Network)
May-21-26 01:00AM	Live Longer and Better. Does Medicine's New Obsession Really Work? (Barrons.com)
May-20-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +6.71%
May-18-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.61%
07:31AM	Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany (Business Wire)
May-15-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +6.59%
12:50PM	Dexcom Just Made A Lofty Promise To Its Investors - Why Analysts Are Bullish (Investor's Business Daily)
07:48AM	Dexcom to add 2 board directors with activist investor Elliott (MedTech Dive)
May-14-26 04:02PM	Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day (Business Wire)
May-13-26 04:30PM	Insulet Corp. stock underperforms Wednesday when compared to competitors (MarketWatch)
May-12-26 09:56AM	Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls (The Fly)
08:56AM	Dexcom gets a new Buy rating at Benchmark on expected margin expansion (Investing.com)
May-05-26 08:30AM	Dexcom to Host Investor Day on May 14, 2026 (Business Wire)
May-01-26 08:30AM	DexCom, Inc. Q1 2026 Earnings Call Summary (Moby)
07:25AM	Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook (Medical Device Network)
03:18AM	DexCom Inc (DXCM) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ... (GuruFocus.com)
Apr-30-26 04:09PM	DexCom: Q1 Earnings Snapshot (Associated Press)
04:02PM	Dexcom Reports First Quarter 2026 Financial Results (Business Wire)
Apr-29-26 10:30AM	Why Medtech Giants Are Quietly Paying Up for AI Diagnostics (PR Newswire)
Apr-21-26 11:59AM	Study Supports GlucoTracks Blood Glucose Monitoring Implant (Exec Edge)
Apr-09-26 06:50PM	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Apr-02-26 08:30AM	Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time (Business Wire)
Apr-01-26 08:30AM	American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA (TMX Newsfile)
Mar-31-26 03:09PM	MiniMed initiated with Buy rating by Bank of America on pipeline-driven growth outlook (Proactive)
Mar-11-26 05:26AM	DexCom price target raised to $84 from $77 at Citi (TipRanks)
02:00AM	Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 (Business Wire)
Mar-09-26 09:45AM	Here's Why DexCom (DXCM) is a Strong Growth Stock (Zacks)
Mar-05-26 08:41AM	Is DexCom Stock Underperforming the Nasdaq? (Barchart)
Feb-26-26 04:15PM	Dexcom Appoints Rick Osterloh to Board of Directors (Business Wire)
08:03AM	Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership (Insider Monkey)
Feb-25-26 08:00PM	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
Feb-24-26 09:29PM	Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat (Insider Monkey)
11:33AM	AdvaMed names Jake Leach as chair of diabetes sector (MedTech Dive)
06:25AM	Medtronics MiniMed prices IPO at up to $784M (MedTech Dive)
Feb-23-26 03:40PM	DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership (Insider Monkey)
Feb-20-26 09:45AM	Why DexCom (DXCM) is a Top Growth Stock for the Long-Term (Zacks)
07:15AM	SENS Eversense 365 Integrated With twiist Gains Full Availability (Zacks)
05:00AM	Senseonics launches automated insulin dosing system with 1-year CGM (MedTech Dive)
Feb-19-26 12:38AM	The 5 Most Interesting Analyst Questions From DexCom's Q4 Earnings Call (StockStory)
Feb-17-26 01:11PM	Medtronic Posts Better-Than-Expected Earnings. Heres Why the Stock Is Falling. (Barrons.com)
Feb-15-26 06:52AM	DexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook (Insider Monkey)
Feb-13-26 04:36PM	Analyst Report: DexCom, Inc. (Morningstar Research) +7.59%
04:34PM	Stocks Settle Slightly Higher as Bond Yields Fall (Barchart)
01:48PM	Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday? (Benzinga)
12:35PM	DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth (Zacks)
12:10PM	Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations (Medical Device Network)
11:31AM	Why Is DexCom (DXCM) Stock Rocketing Higher Today (StockStory)
08:55AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
08:30AM	DexCom, Inc. Q4 2025 Earnings Call Summary (Moby)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brown Michael Jon	EVP Chief Legal Compliance Off	Oct 15 '26	Sale	85.48	1,700	145,316	98,185	Oct 19 06:42 PM
MICHAEL BROWN	Officer	Oct 15 '26	Proposed Sale	85.48	1,700	145,316		Oct 15 04:02 PM
Stern Sadie	EVP Chief People & Culture Off	Sep 28 '26	Sale	86.15	2,565	220,975	123,478	Sep 30 04:15 PM
SADIE STERN	Officer	Sep 28 '26	Proposed Sale	86.15	2,565	220,975		Sep 28 04:12 PM
AUGUSTINOS NICHOLAS	Director	Sep 15 '26	Sale	84.04	6,539	549,538	29,293	Sep 16 04:26 PM
AUGUSTINOS NICHOLAS	Director	Sep 14 '26	Sale	84.02	1,550	130,231	35,832	Sep 16 04:26 PM
Brown Michael Jon	EVP Chief Legal Compliance Off	Sep 15 '26	Sale	84.04	1,700	142,868	99,885	Sep 16 04:25 PM
MICHAEL BROWN	Officer	Sep 15 '26	Proposed Sale	84.04	1,700	142,868		Sep 15 04:01 PM
AUGUSTINOS NICHOLAS	Director	Sep 15 '26	Proposed Sale	84.04	6,539	549,538		Sep 15 09:52 AM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 10 '26	Sale	83.27	3,638	302,936	146,828	Sep 14 04:02 PM
AUGUSTINOS NICHOLAS	Director	Sep 14 '26	Proposed Sale	84.02	1,550	130,231		Sep 14 09:42 AM
JEREME SYLVAIN	Officer	Sep 10 '26	Proposed Sale	83.27	3,638	302,936		Sep 10 04:05 PM
Stern Sadie	EVP Chief People & Culture Off	Aug 27 '26	Sale	88.37	2,565	226,669	126,043	Aug 28 04:57 PM
SADIE STERN	Officer	Aug 27 '26	Proposed Sale	88.37	2,565	226,669		Aug 27 04:10 PM
SAYER KEVIN R	Executive Chair	Aug 20 '26	Sale	90.01	26,756	2,408,242	302,214	Aug 24 04:01 PM
KEVIN R SAYER	Officer	Aug 20 '26	Proposed Sale	90.01	26,756	2,408,241		Aug 20 04:49 PM
Brown Michael Jon	EVP Chief Legal Compliance Off	Aug 14 '26	Sale	91.93	1,700	156,281	102,953	Aug 17 04:08 PM
MICHAEL BROWN	Officer	Aug 14 '26	Proposed Sale	91.93	1,700	156,281		Aug 14 04:22 PM
Heller Bridgette P	Director	Aug 12 '26	Sale	88.29	1,012	89,349	29,570	Aug 13 04:04 PM
Heller Bridgette P	Director	Aug 12 '26	Proposed Sale	88.29	1,012	89,349		Aug 12 10:22 AM
FOLETTA MARK G	Director	Aug 03 '26	Sale	85.32	2,000	170,640	48,852	Aug 04 04:38 PM
FOLETTA MARK G	Director	Jul 31 '26	Sale	80.00	2,000	160,000	50,852	Aug 04 04:38 PM
FOLETTA MARK G	Director	Aug 03 '26	Proposed Sale	85.32	2,000	170,640		Aug 03 04:10 PM
FOLETTA MARK G	Director	Jul 31 '26	Proposed Sale	80.00	2,000	160,000		Jul 31 04:06 PM
SAYER KEVIN R	Executive Chair	Jul 20 '26	Sale	76.32	26,756	2,041,999	328,970	Jul 21 04:58 PM
KEVIN R SAYER	Officer	Jul 20 '26	Proposed Sale	76.32	26,756	2,041,999		Jul 20 04:05 PM
Brown Michael Jon	EVP Chief Legal Compliance Off	Jul 15 '26	Sale	74.42	1,700	126,514	104,653	Jul 16 05:06 PM
MICHAEL BROWN	Officer	Jul 15 '26	Proposed Sale	74.42	1,700	126,514		Jul 15 04:04 PM
SAYER KEVIN R	Executive Chair	Jul 06 '26	Sale	72.00	26,756	1,926,432	355,726	Jul 07 04:09 PM
KEVIN R SAYER	Officer	Jul 06 '26	Proposed Sale	72.00	26,756	1,926,432		Jul 06 04:21 PM
Brown Michael Jon	EVP Chief Legal Compliance Off	Jun 15 '26	Sale	75.55	1,700	128,435	106,353	Jun 17 04:32 PM
FOLETTA MARK G	Director	Jun 15 '26	Sale	74.13	4,000	296,540	52,852	Jun 17 04:32 PM
FOLETTA MARK G	Director	Jun 15 '26	Proposed Sale	75.70	4,000	302,800		Jun 15 05:47 PM
MICHAEL BROWN	Officer	Jun 15 '26	Proposed Sale	75.55	1,700	128,435		Jun 15 04:01 PM
Coleman Jon	EVP, Chief Commercial Officer	Jun 04 '26	Sale	74.13	4,911	364,052	95,450	Jun 05 04:17 PM
Coleman Jon	EVP, Chief Commercial Officer	Jun 03 '26	Sale	73.00	4,912	358,576	100,361	Jun 05 04:17 PM
JON C COLEMAN	Officer	Jun 04 '26	Proposed Sale	74.13	4,911	364,052		Jun 04 04:10 PM
JON C COLEMAN	Officer	Jun 03 '26	Proposed Sale	73.00	4,912	358,576		Jun 03 04:03 PM
SAYER KEVIN R	Executive Chair	May 21 '26	Sale	72.00	26,759	1,926,648	382,482	May 26 04:18 PM
KEVIN R SAYER	Officer	May 21 '26	Proposed Sale	72.00	26,759	1,926,648		May 21 05:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	May 15 '26	Sale	59.91	1,700	101,847	109,504	May 19 04:34 PM
MICHAEL BROWN	Officer	May 15 '26	Proposed Sale	59.91	1,700	101,847		May 15 04:05 PM
Heller Bridgette P	Director	May 12 '26	Sale	60.01	1,012	60,730	25,007	May 14 04:39 PM
Heller Bridgette P	Director	May 12 '26	Proposed Sale	60.01	1,012	60,730		May 12 09:47 AM
Brown Michael Jon	EVP, Chief Legal Officer	Apr 15 '26	Sale	63.04	1,700	107,168	111,204	Apr 16 07:27 PM
MICHAEL BROWN	Officer	Apr 15 '26	Proposed Sale	63.04	1,700	107,168		Apr 15 04:06 PM
Brown Michael Jon	EVP, Chief Legal Officer	Mar 16 '26	Sale	64.85	1,700	110,245	112,904	Mar 18 04:07 PM
MICHAEL BROWN	Officer	Mar 16 '26	Proposed Sale	64.85	1,700	110,245		Mar 16 04:02 PM
Heller Bridgette P	Director	Feb 12 '26	Sale	68.01	1,012	68,826	26,019	Feb 17 04:36 PM
Heller Bridgette P	Director	Feb 12 '26	Proposed Sale	68.01	1,012	68,826		Feb 12 09:51 AM
Collins Richard Alexander	Director	Nov 14 '25	Sale	59.05	2,906	171,599	35,088	Nov 17 05:52 PM
Collins Richard Alexander	Director	Nov 14 '25	Proposed Sale	59.05	2,906	171,599		Nov 14 09:50 AM
Heller Bridgette P	Director	Nov 12 '25	Sale	58.07	1,012	58,767	27,031	Nov 12 05:14 PM
Heller Bridgette P	Director	Nov 12 '25	Proposed Sale	58.07	1,012	58,767		Nov 12 10:52 AM
Leach Jacob Steven	President & COO	Nov 10 '25	Buy	55.04	18,200	1,001,702	331,697	Nov 10 07:13 PM
Collins Richard Alexander	Director	Nov 10 '25	Sale	55.17	3,948	217,811	37,994	Nov 10 07:12 PM
Collins Richard Alexander	Director	Nov 10 '25	Proposed Sale	55.17	3,948	217,811		Nov 10 09:52 AM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Executive Chairman of the BoardMr. Kevin Ronald Sayer

PresidentMr. Jacob Steven Leach

Executive VPMr. Jereme M. Sylvain CPA

Executive VPMr. Michael Jon Brown J.D.

Executive VPMs. Sadie M. Stern

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your Finviz experience